- Diagnosis and treatment of Waldenström Macroglobulinemia2019 | Central Library of Charles University
- Waldenstrom's macroglobulinemia with pulmonary amyloidosis1998 | Third Faculty of Medicine
- Zanubrutinib Versus Ibrutinib in Symptomatic Waldenström Macroglobulinemia: Final Analysis From the Randomized Phase III ASPEN Study2023 | Publication without faculty affiliation
- Diagnosis and treatment of Waldenström's macroglobulinemia2014 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- Combination of serum microRNA-320a and microRNA-320b as a marker for Waldenstrom macroglobulinemia2015 | Publication without faculty affiliation
- A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenström macroglobulinemia: the ASPEN study2020 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- Zanubrutinib for the treatment of MYD88 wild-type Waldenström macroglobulinemia: a substudy of the phase 3 ASPEN trial2020 | First Faculty of Medicine
- IgM myeloma: A multicenter retrospective study of 134 patient2017 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- Clinical case: idelalisib-induced immunoglobulin flare2017 | Third Faculty of Medicine, Central Library of Charles University
- The risk of transformation in monoclonal gammopathy of undetermined significance in malignant monoclonal gammopathy2013 | Faculty of Medicine in Hradec Králové
- Treatment of associated anemia in different hematological disorders with epoetin alpha2004 | First Faculty of Medicine
- High-risk monoclonal gammopathy of undetermined significance - to treat or not to treat?2013 | Faculty of Medicine in Hradec Králové
- Genome-wide meta-analysis of monoclonal gammopathy of undetermined significance (MGUS) identifies risk loci impacting IRF-62022 | First Faculty of Medicine, Faculty of Medicine in Pilsen